Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 18/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.60 |
| ▸ | EGFR | P00533 | 3/20 | 0.56 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.42 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5635696 | 1.00 | ERBB2 (0.70) | ERBB2KCNH2EGFRPIK3CDPIK3R1 | |
| SCHEMBL5570344 | 0.92 | ERBB2 (0.83) | ERBB2KCNH2EGFRMKNK2 | |
| SCHEMBL5636901 | 0.92 | ERBB2 (0.83) | ERBB2KCNH2EGFRMKNK2 | |
| SCHEMBL5637195 | 0.90 | ERBB2 (0.85) | ERBB2KCNH2EGFRMKNK2 | |
| SCHEMBL5635726 | 0.90 | ERBB2 (0.84) | ERBB2KCNH2EGFR | |
| SCHEMBL5636108 | 0.90 | ERBB2 (0.84) | ERBB2KCNH2EGFR | |
| SCHEMBL5573774 | 0.90 | ERBB2 (0.84) | ERBB2KCNH2EGFR | |
| SCHEMBL5635741 | 0.90 | ERBB2 (0.72) | ERBB2KCNH2EGFRMKNK2 | |
| SCHEMBL5570073 | 0.90 | ERBB2 (0.72) | ERBB2KCNH2EGFRMKNK2 | |
| SCHEMBL5572891 | 0.90 | ERBB2 (0.84) | ERBB2KCNH2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756088-A1 | QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES | AstraZeneca AB (SE) | 2007-02-28 | — | — | EP | claimed |
| WO-2005118572-A1 | QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES | ASTRAZENECA AB (SE) | 2005-12-15 | — | — | WO | claimed |